Intrommune Therapeutics

Intrommune Therapeutics

生物技术研究

Dedicated to developing safe and effective options for peanut and other food allergies

关于我们

Intrommune Therapeutics, Inc. is a biotechnology company located in New York, NY. Intrommune is developing food allergy immunotherapies that are delivered while you brush your teeth, a lifelong habit that is ingrained in most people and ensures daily use of our product. Intrommune's elegant new treatment platform for food allergies is expected to be safe, effective and convenient. Intrommune’s first product is a therapy for patients who suffer from peanut allergy. Intrommune is developing the oral mucosal immunotherapy (OMIT) platform for food allergies. It is a long-term solution for the 220 million, including 32 million people in the U.S., who suffer from this life-altering condition.

网站
https://www.intrommune.com/
所属行业
生物技术研究
规模
2-10 人
总部
New York
类型
私人持股
创立
2015

地点

Intrommune Therapeutics员工

动态

相似主页

查看职位

融资